Location · Washington D.C., DC
Clinical trials in Washington D.C., DC
221 recruiting studies have a site in Washington D.C., and 73 of them accept healthy volunteers.
221 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Novartis Pharmaceuticals
- Location
- Washington D.C., DC + 6 other US sites
- Eligibility basics
- Ages 6–11
- Recruiting
J-Valve Transfemoral Pivotal Study
JC Medical, Inc., an affiliate of Edwards Lifesciences LLC
- Location
- Washington D.C., DC + 33 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
argenx
- Location
- Washington D.C., DC + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Calcilytix Therapeutics, Inc., a BridgeBio company
- Location
- Washington D.C., DC + 3 other US sites
- Eligibility basics
- Ages 0 mo–17
- RecruitingPhase 4
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
ARS Pharmaceuticals, Inc.
- Location
- Washington D.C., DC + 5 other US sites
- Eligibility basics
- Ages 4+
- RecruitingPhase 2
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
Merck Sharp & Dohme LLC
- Location
- Washington D.C., DC + 8 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 1
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
Amylyx Pharmaceuticals Inc.
- Location
- Washington D.C., DC + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
- Location
- Washington D.C., DC + 1 other US site
- Eligibility basics
- Ages 6–17
- RecruitingPhase 2
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
BioMarin Pharmaceutical
- Location
- Washington D.C., DC + 6 other US sites
- Eligibility basics
- Ages 0 mo–3
- RecruitingPhase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Intellia Therapeutics
- Location
- Washington D.C., DC + 36 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
Skingenix, Inc.
- Location
- Washington D.C., DC + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Direct Biologics, LLC
- Location
- Washington D.C., DC + 30 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Washington D.C., DC + 34 other US sites
- Eligibility basics
- Ages 12–18
- Recruiting
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Endospan Ltd.
- Location
- Washington D.C., DC + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Washington D.C., DC + 57 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Non-invasive Central Venous Pressure Estimation in Pediatric Patients
Compremium AG
- Location
- Washington D.C., DC
- Eligibility basics
- Up to age 21
- RecruitingPhase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
- Location
- Washington D.C., DC + 101 other US sites
- Eligibility basics
- Ages 18–50 · Women only
- Recruiting
EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment
BrainQ Technologies Ltd.
- Location
- Washington D.C., DC + 6 other US sites
- Eligibility basics
- Ages 22–80
- RecruitingPhase 2
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)
Evon Medics LLC
- Location
- Washington D.C., DC + 1 other US site
- Eligibility basics
- Ages 18–85
- RecruitingPhase 1/Phase 2
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
ViiV Healthcare
- Location
- Washington D.C., DC + 5 other US sites
- Eligibility basics
- Ages 6–12
- Recruiting
Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds
Synedgen, Inc.
- Location
- Washington D.C., DC + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
NIAID Centralized Sequencing Protocol
National Institute of Allergy and Infectious Diseases (NIAID)
- Location
- Washington D.C., DC + 1 other US site
- Eligibility basics
- Ages 0 mo–100
- RecruitingHealthy volunteers
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
National Human Genome Research Institute (NHGRI)
- Location
- Washington D.C., DC + 23 other US sites
- Eligibility basics
- Ages 1 mo–100
- RecruitingHealthy volunteersPhase 2
Prevention of Postpartum Hemorrhage With Tranexamic Acid
Inova Health Care Services
- Location
- Washington D.C., DC + 1 other US site
- Eligibility basics
- Ages 18–50 · Women only